[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Edwards Lifesciences Corp (EW)

Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 48,943,000
  • Shares Outstanding, K 575,800
  • Annual Sales, $ 6,068 M
  • Annual Income, $ 1,074 M
  • EBIT $ 1,347 M
  • EBITDA $ 1,504 M
  • 60-Month Beta 0.86
  • Price/Sales 8.14
  • Price/Cash Flow 30.06
  • Price/Book 4.79

Options Overview Details

View History
  • Implied Volatility 38.05% (-0.75%)
  • Historical Volatility 25.95%
  • IV Percentile 88%
  • IV Rank 71.27%
  • IV High 46.09% on 10/24/25
  • IV Low 18.11% on 08/28/25
  • Expected Move (DTE 31) 6.74 (8.06%)
  • Put/Call Vol Ratio 0.75
  • Today's Volume 1,341
  • Volume Avg (30-Day) 884
  • Put/Call OI Ratio 0.96
  • Today's Open Interest 43,748
  • Open Int (30-Day) 45,080
  • Expected Range 76.94 to 90.42

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.73
  • Number of Estimates 9
  • High Estimate $0.75
  • Low Estimate $0.72
  • Prior Year $0.67
  • Growth Rate Est. (year over year) +8.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
83.29 +0.37%
on 07/21/26
96.29 -13.18%
on 07/07/26
-3.76 (-4.30%)
since 06/18/26
3-Month
76.49 +9.30%
on 05/11/26
96.29 -13.18%
on 07/07/26
+3.89 (+4.88%)
since 04/21/26
52-Week
72.30 +15.63%
on 10/13/25
96.29 -13.18%
on 07/07/26
+7.04 (+9.20%)
since 07/21/25

Most Recent Stories

More News
Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2026 after the market closes on Thursday July 23, and will host a conference call at 5:00 p.m. ET...

EW : 83.66 (-2.41%)
Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...

EW : 83.66 (-2.41%)
What You Need To Know Ahead of Edwards Lifesciences' Earnings Release

Edwards Lifesciences is scheduled to report its second-quarter results soon, and analysts expect a single-digit earnings rise.

EW : 83.66 (-2.41%)
XLV : 159.53 (+0.18%)
$SPX : 7,508.53 (+0.88%)
Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves

Edwards Lifesciences (NYSE: EW) today announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which reinforce the company's leadership...

EW : 83.66 (-2.41%)
Stocks Indexes Finish Mostly Lower as Chipmakers Retreat

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.57%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.64%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.89%. June E-mini...

TSCO : 29.94 (-1.19%)
OXY : 56.13 (+1.70%)
PLAY : 10.73 (+5.30%)
FANG : 198.88 (+1.79%)
AMD : 543.70 (+7.97%)
SPY : 748.82 (+0.91%)
MU : 974.44 (+12.59%)
BKR : 56.49 (+2.43%)
ORCL : 126.50 (+4.22%)
QQQ : 709.81 (+1.98%)
EW : 83.66 (-2.41%)
SPCX : 127.82 (+6.65%)
Broader Market Weakens as Energy and Software Stocks Fall

The S&P 500 Index ($SPX ) (SPY ) today is down -0.18%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.69%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.83%. June E-mini S&P futures (ESM26...

ALK : 46.08 (+0.09%)
HL : 15.32 (+7.21%)
CDE : 15.21 (+7.42%)
TSCO : 29.94 (-1.19%)
OXY : 56.13 (+1.70%)
PLAY : 10.73 (+5.30%)
FANG : 198.88 (+1.79%)
SPY : 748.82 (+0.91%)
BKR : 56.49 (+2.43%)
ORCL : 126.50 (+4.22%)
AAL : 15.35 (+1.39%)
QQQ : 709.81 (+1.98%)
Stocks Supported by Lower Crude Oil Prices and Bond Yields

The S&P 500 Index ($SPX ) (SPY ) today is up +0.11%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.57%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.18%. June E-mini S&P futures (ESM26...

ALK : 46.08 (+0.09%)
MPC : 317.56 (+0.71%)
SNDK : 1,568.96 (+12.80%)
HL : 15.32 (+7.21%)
CDE : 15.21 (+7.42%)
ADI : 383.98 (+3.09%)
TSCO : 29.94 (-1.19%)
PLAY : 10.73 (+5.30%)
FANG : 198.88 (+1.79%)
STX : 896.65 (+11.74%)
WDC : 550.31 (+12.90%)
SCCO : 186.04 (+6.27%)
Is Edwards Lifesciences Stock Underperforming the Nasdaq?

Despite trailing the broader Nasdaq Composite over the last 12 months, Edwards Lifesciences continues to earn strong support from analysts.

EW : 83.66 (-2.41%)
$NASX : 25,856.03 (+1.36%)
SYK : 315.61 (-1.11%)
Are Wall Street Analysts Bullish on Edwards Lifesciences Stock?

While Edwards Lifesciences has considerably underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

EVR : 340.53 (+2.10%)
EW : 83.66 (-2.41%)
XLV : 159.53 (+0.18%)
$SPX : 7,508.53 (+0.88%)
Edwards Lifesciences Announces Appointment of CFO

Edwards Lifesciences (NYSE: EW) today announced the appointment of Theodora (“Doretta”) Mistras as the company’s corporate vice president and chief financial officer (CFO), effective at the end of...

EW : 83.66 (-2.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair...

See More

Key Turning Points

3rd Resistance Point 87.30
2nd Resistance Point 86.79
1st Resistance Point 85.89
Last Price 83.66
1st Support Level 84.49
2nd Support Level 83.98
3rd Support Level 83.08

See More

52-Week High 96.29
Fibonacci 61.8% 87.13
Fibonacci 50% 84.29
Last Price 83.66
Fibonacci 38.2% 81.46
52-Week Low 72.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.